- Home
- PW vs APVO Comparison
PW vs APVO Comparison
Compare PW & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PW
- APVO
- Stock Information
- Founded
- PW 1967
- APVO 2016
- Country
- PW United States
- APVO United States
- Employees
- PW N/A
- APVO N/A
- Industry
- PW Real Estate Investment Trusts
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- PW Real Estate
- APVO Health Care
- Exchange
- PW Nasdaq
- APVO Nasdaq
- Market Cap
- PW 3.7M
- APVO 3.3M
- IPO Year
- PW N/A
- APVO N/A
- Fundamental
- Price
- PW $1.15
- APVO $0.67
- Analyst Decision
- PW
- APVO Strong Buy
- Analyst Count
- PW 0
- APVO 1
- Target Price
- PW N/A
- APVO $296.00
- AVG Volume (30 Days)
- PW 15.9K
- APVO 8.7M
- Earning Date
- PW 05-09-2025
- APVO 05-07-2025
- Dividend Yield
- PW N/A
- APVO N/A
- EPS Growth
- PW N/A
- APVO N/A
- EPS
- PW N/A
- APVO N/A
- Revenue
- PW $3,049,875.00
- APVO N/A
- Revenue This Year
- PW N/A
- APVO N/A
- Revenue Next Year
- PW N/A
- APVO N/A
- P/E Ratio
- PW N/A
- APVO N/A
- Revenue Growth
- PW 37.23
- APVO N/A
- 52 Week Low
- PW $0.40
- APVO $0.60
- 52 Week High
- PW $2.75
- APVO $51.06
- Technical
- Relative Strength Index (RSI)
- PW 55.36
- APVO 30.74
- Support Level
- PW $1.06
- APVO $0.60
- Resistance Level
- PW $1.10
- APVO $0.80
- Average True Range (ATR)
- PW 0.06
- APVO 0.19
- MACD
- PW 0.01
- APVO 0.03
- Stochastic Oscillator
- PW 83.94
- APVO 6.97
About PW Power REIT (MD)
Power REIT is an internally managed real estate investment trust (REIT) that owns a portfolio of real estate assets related to transportation, energy infrastructure, and Controlled Environment Agriculture (CEA) in the United States. Its investment portfolio comprises solar farm lands, railroad real estate, and various Controlled Environment Agriculture properties in the form of greenhouses for the cultivation of food and cannabis. In addition, the company is focused on opportunities in the form of investing in distressed situations, including debt and other types of secured interests in real estate, distressed properties, and real estate-related companies.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.